{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:23:45Z","timestamp":1767857025467,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T00:00:00Z","timestamp":1382918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. We therefore aim to evaluate the factors associated with the number of late blood transfusion in very preterm infants in a unit where the routine use of EPO has been discontinued.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comparative \u201cbefore-after\u201d study was carried out in premature infants born before 32 weeks postmenstrual age (PMA), over a period of one year before (EPO group) and one year after (non-EPO group) the discontinuation of EPO therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 48 infants were included in the study (EPO=21; non-EPO=27). The number of infants transfused after the 15 day of life (D15) and the number of transfusions per infant after D15 were not significantly different between the two groups. In a multivariate analysis, the gestational age and the volume of blood drawn off during the first month of life significantly influenced the need for transfusions after the 15th day of life, independently of the treatment with EPO. The hemoglobin levels measured at different times of hospitalization (median postnatal age: 16, 33 and 67 days) were not significantly different between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study shows that the discontinuation of EPO did not change the number of late transfusions. Even when a policy limiting phlebotomy losses is used, blood loss is an important and independent risk factor for late transfusion of very preterm infants.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2431-13-176","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T18:01:00Z","timestamp":1382983260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants"],"prefix":"10.1186","volume":"13","author":[{"given":"Odile","family":"Becquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Guyot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Besnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Papouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Lapillonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"issue":"5","key":"1256_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0022-3476(05)82671-X","volume":"116","author":"DS Halperin","year":"1990","unstructured":"Halperin DS, Wacker P, Lacourt G, Felix M, Babel JF, Aapro M, Wyss M: Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr. 1990, 116 (5): 779-786. 10.1016\/S0022-3476(05)82671-X.","journal-title":"J Pediatr"},{"issue":"4","key":"1256_CR2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.92.4.519","volume":"92","author":"J Messer","year":"1993","unstructured":"Messer J, Haddad J, Donato L, Astruc D, Matis J: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics. 1993, 92 (4): 519-523.","journal-title":"Pediatrics"},{"issue":"17","key":"1256_CR3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199404283301701","volume":"330","author":"RF Maier","year":"1994","unstructured":"Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G, et al: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. The New England journal of medicine. 1994, 330 (17): 1173-1178.","journal-title":"European Multicentre Erythropoietin Study Group. The New England journal of medicine"},{"issue":"5","key":"1256_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1203\/00006450-199311000-00022","volume":"34","author":"V Soubasi","year":"1993","unstructured":"Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D: In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res. 1993, 34 (5): 675-679. 10.1203\/00006450-199311000-00022.","journal-title":"Pediatr Res"},{"issue":"3 Spec No","key":"1256_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.68.3_Spec_No.291","volume":"68","author":"AJ Emmerson","year":"1993","unstructured":"Emmerson AJ, Coles HJ, Stern CM, Pearson TC: Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993, 68 (3 Spec No): 291-296. 10.1136\/adc.68.3_Spec_No.291.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1256_CR6","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1542\/peds.2013-0143","volume":"132","author":"RK Ohls","year":"2013","unstructured":"Ohls RK, Christensen RD, Kamath-Rayne BD, Rosenberg A, Wiedmeier SE, Roohi M, Lacy CB, Lambert DK, Burnett JJ, Pruckler B, et al: A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants. Pediatrics. 2013, 132 (1): e119-127. 10.1542\/peds.2013-0143.","journal-title":"Pediatrics"},{"issue":"2","key":"1256_CR7","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1542\/peds.106.2.e19","volume":"106","author":"JC Lin","year":"2000","unstructured":"Lin JC, Strauss RG, Kulhavy JC, Johnson KJ, Zimmerman MB, Cress GA, Connolly NW, Widness JA: Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics. 2000, 106 (2): E19-10.1542\/peds.106.2.e19.","journal-title":"Pediatrics"},{"issue":"2","key":"1256_CR8","doi-asserted-by":"publisher","first-page":"F96","DOI":"10.1136\/fn.84.2.F96","volume":"84","author":"AR Franz","year":"2001","unstructured":"Franz AR, Pohlandt F: Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary?. Arch Dis Child Fetal Neonatal Ed. 2001, 84 (2): F96-F100. 10.1136\/fn.84.2.F96.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"1256_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tmrv.2005.08.003","volume":"20","author":"RG Strauss","year":"2006","unstructured":"Strauss RG: Controversies in the management of the anemia of prematurity using single-donor red blood cell transfusions and\/or recombinant human erythropoietin. Transfus Med Rev. 2006, 20 (1): 34-44. 10.1016\/j.tmrv.2005.08.003.","journal-title":"Transfus Med Rev"},{"issue":"1","key":"1256_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.semperi.2008.10.006","volume":"33","author":"N Bishara","year":"2009","unstructured":"Bishara N, Ohls RK: Current controversies in the management of the anemia of prematurity. Semin Perinatol. 2009, 33 (1): 29-34. 10.1053\/j.semperi.2008.10.006.","journal-title":"Semin Perinatol"},{"issue":"3","key":"1256_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1046\/j.1537-2995.2001.41030406.x","volume":"41","author":"EC Vamvakas","year":"2001","unstructured":"Vamvakas EC, Strauss RG: Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion. 2001, 41 (3): 406-415. 10.1046\/j.1537-2995.2001.41030406.x.","journal-title":"Transfusion"},{"issue":"4","key":"1256_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1542\/peds.108.4.934","volume":"108","author":"RK Ohls","year":"2001","unstructured":"Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, Stark AR, Shankaran S, Donovan EF, Close NC, et al: Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics. 2001, 108 (4): 934-942. 10.1542\/peds.108.4.934.","journal-title":"Pediatrics"},{"issue":"1","key":"1256_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1067\/mpd.2002.124309","volume":"141","author":"RF Maier","year":"2002","unstructured":"Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, Groneck P, Hammer H, Kossel H, Verellen G, et al: Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr. 2002, 141 (1): 8-15. 10.1067\/mpd.2002.124309.","journal-title":"J Pediatr"},{"key":"1256_CR14","volume-title":"Cochrane Database Syst Rev","author":"SM Aher","year":"2006","unstructured":"Aher SM, Ohlsson A: Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2006, 3: CD004865"},{"issue":"1","key":"1256_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/jpet.109.159905","volume":"332","author":"KJ Freise","year":"2010","unstructured":"Freise KJ, Widness JA, Veng-Pedersen P: Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. J Pharmacol Exp Ther. 2010, 332 (1): 229-237. 10.1124\/jpet.109.159905.","journal-title":"J Pharmacol Exp Ther"},{"key":"1256_CR16","volume-title":"Cochrane Database Syst Rev","author":"S Aher","year":"2006","unstructured":"Aher S, Ohlsson A: Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2006, 3: CD004868"},{"key":"1256_CR17","volume-title":"Cochrane Database Syst Rev","author":"A Ohlsson","year":"2006","unstructured":"Ohlsson A, Aher SM: Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2006, 3: CD004863"},{"key":"1256_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1246-7820(01)00213-0","volume":"9","author":"AFSSAPS","year":"2002","unstructured":"AFSSAPS: Transfusion de Globules rouges homologues : produits, indications, alternatives. Methode g\u00e9n\u00e9rale, Recommandation. Transfus Clin Biol. 2002, 9: 33-56. 10.1016\/S1246-7820(01)00213-0.","journal-title":"Transfus Clin Biol"},{"key":"1256_CR19","volume-title":"Cochrane Database Syst Rev","author":"SM Aher","year":"2012","unstructured":"Aher SM, Ohlsson A: Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2012, 10: CD004865"},{"issue":"2 Pt 1","key":"1256_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1542\/peds.110.2.389","volume":"110","author":"R Carbajal","year":"2002","unstructured":"Carbajal R, Lenclen R, Gajdos V, Jugie M, Paupe A: Crossover trial of analgesic efficacy of glucose and pacifier in very preterm neonates during subcutaneous injections. Pediatrics. 2002, 110 (2 Pt 1): 389-393.","journal-title":"Pediatrics"},{"issue":"6","key":"1256_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1440-1754.1996.tb00965.x","volume":"32","author":"PJ Beeby","year":"1996","unstructured":"Beeby PJ, Bhutap T, Taylor LK: New South Wales population-based birthweight percentile charts. J Paediatr Child Health. 1996, 32 (6): 512-518. 10.1111\/j.1440-1754.1996.tb00965.x.","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"1256_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978, 92 (4): 529-534. 10.1016\/S0022-3476(78)80282-0.","journal-title":"J Pediatr"},{"key":"1256_CR23","volume-title":"Cochrane Database Syst Rev","author":"R Whyte","year":"2011","unstructured":"Whyte R, Kirpalani H: Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev. 2011, 11: CD000512"},{"issue":"10","key":"1256_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/01.smj.0000233213.28362.3b","volume":"99","author":"HJ Birenbaum","year":"2006","unstructured":"Birenbaum HJ, Pane MA, Helou SM, Starr KP: Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants. South Med J. 2006, 99 (10): 1059-1062. 10.1097\/01.smj.0000233213.28362.3b.","journal-title":"South Med J"},{"issue":"9","key":"1256_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0929-693X(99)80586-7","volume":"6","author":"AS Trentesaux","year":"1999","unstructured":"Trentesaux AS, Egreteau L, Santerne B, Morville P: Recombinant human erythropoietin in premature infants. Evaluation of a one year experience. Arch Pediatr. 1999, 6 (9): 944-951. 10.1016\/S0929-693X(99)80586-7.","journal-title":"Arch Pediatr"},{"issue":"5","key":"1256_CR26","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1542\/peds.105.5.1066","volume":"105","author":"H Donato","year":"2000","unstructured":"Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguia M, Digregorio J, Vecchiarelli C, Valverde R, Garcia C, et al: Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics. 2000, 105 (5): 1066-1072. 10.1542\/peds.105.5.1066.","journal-title":"Pediatrics"},{"issue":"5","key":"1256_CR27","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1542\/peds.2006-1113","volume":"118","author":"N Haiden","year":"2006","unstructured":"Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, Kohlhauser-Vollmuth C, Jilma B, Pollak A: Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics. 2006, 118 (5): 2004-2013. 10.1542\/peds.2006-1113.","journal-title":"Pediatrics"},{"issue":"12","key":"1256_CR28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s12098-008-0225-0","volume":"75","author":"SF Khatami","year":"2008","unstructured":"Khatami SF, Mamouri G, Torkaman M: Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants. Indian J Pediatr. 2008, 75 (12): 1227-1230. 10.1007\/s12098-008-0225-0.","journal-title":"Indian J Pediatr"},{"issue":"8","key":"1256_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3109\/14767058.2010.545917","volume":"24","author":"A Tempera","year":"2011","unstructured":"Tempera A, Stival E, Piastra M, De Luca D, Ottaviano C, Tramontozzi P, Marconi M, Cafforio C, Marcozzi P, Rossi N, et al: Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants. J Matern Fetal Neonatal Med. 2011, 24 (8): 1060-1064. 10.3109\/14767058.2010.545917.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1256_CR30","volume-title":"Cochrane Database Syst Rev","author":"A Ohlsson","year":"2012","unstructured":"Ohlsson A, Aher SM: Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2012, 9: CD004863"},{"issue":"4","key":"1256_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/j.semperi.2012.04.004","volume":"36","author":"U Guillen","year":"2012","unstructured":"Guillen U, Cummings JJ, Bell EF, Hosono S, Frantz AR, Maier RF, Whyte RK, Boyle E, Vento M, Widness JA, et al: International survey of transfusion practices for extremely premature infants. Semin Perinatol. 2012, 36 (4): 244-247. 10.1053\/j.semperi.2012.04.004.","journal-title":"Semin Perinatol"},{"issue":"1","key":"1256_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1542\/peds.2008-0338","volume":"123","author":"RK Whyte","year":"2009","unstructured":"Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, et al: Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009, 123 (1): 207-213. 10.1542\/peds.2008-0338.","journal-title":"Pediatrics"},{"issue":"6","key":"1256_CR33","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1542\/peds.2004-1884","volume":"115","author":"EF Bell","year":"2005","unstructured":"Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB: Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005, 115 (6): 1685-1691. 10.1542\/peds.2004-1884.","journal-title":"Pediatrics"},{"issue":"4","key":"1256_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/09297049.2010.544647","volume":"17","author":"TE McCoy","year":"2011","unstructured":"McCoy TE, Conrad AL, Richman LC, Lindgren SD, Nopoulos PC, Bell EF: Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol. 2011, 17 (4): 347-367. 10.1080\/09297049.2010.544647.","journal-title":"Child Neuropsychol"},{"issue":"5","key":"1256_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/archpediatrics.2010.269","volume":"165","author":"PC Nopoulos","year":"2011","unstructured":"Nopoulos PC, Conrad AL, Bell EF, Strauss RG, Widness JA, Magnotta VA, Zimmerman MB, Georgieff MK, Lindgren SD, Richman LC: Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med. 2011, 165 (5): 443-450. 10.1001\/archpediatrics.2010.269.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"1256_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archpedi.1997.02170380031005","volume":"151","author":"PJ Kling","year":"1997","unstructured":"Kling PJ, Sullivan TM, Leftwich ME, Roe DJ: Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants. Arch Pediatr Adolesc Med. 1997, 151 (1): 27-31. 10.1001\/archpedi.1997.02170380031005.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"1256_CR37","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1542\/peds.2004-1680","volume":"115","author":"JA Widness","year":"2005","unstructured":"Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK: Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics. 2005, 115 (5): 1299-1306. 10.1542\/peds.2004-1680.","journal-title":"Pediatrics"},{"issue":"1","key":"1256_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","volume":"95","author":"KM Shannon","year":"1995","unstructured":"Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB, et al: Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995, 95 (1): 1-8.","journal-title":"Pediatrics"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-13-176\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-13-176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T20:16:42Z","timestamp":1646943402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-13-176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-13-176","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]},"assertion":[{"value":"30 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"176"}}